The aim of this paper is to discuss a behavioral Bayes approach to the question of the size of a clinical trial. The optimal size is obtained by maximizing the expected net benefit function, which is the expected benefit from subsequent use of the new treatment minus the cost of the trial. A plausible model for the number of subsequent users of the new treatment is introduced.
AdcockC.J.Sample size determination: a review. Statistician.1997; 46: 261–283.
2.
AdcockC.J.A Bayesian approach to calculating sample sizes. Statistician.1988; 37: 433–439.
3.
SpiegelhalterD.J., FreemanL.S., ParmarM.K.B.Bayesian approaches to randomized trials. JR Stat Soc A.1994; 157: 357–416.
4.
Pham-GiaT., TurkkanN.Determination of exact sample sizes in the Bayesian estimation of the difference of two proportions. Statistician.2003; 52: 131–150.
5.
LindleyD.V.The choice of sample size. Statistician.1997; 46: 129–138.
6.
GittinsJ.C., PezeshkH.How large should a clinical trial be?Statistician.2000; 49: 177–187.
7.
PezeshkH., GittinsJ.C.A fully Bayesian approach to calculating sample sizes for clinical trials with binary responses. Drug Inf J.2002; 36: 143–150.
8.
PezeshkH.Bayesian techniques for sample size determination in clinical trials; a short review. Stat Methods Med Res.2003; 12: 489–504.
9.
WolframS.Mathematical a System for Doing Mathematics by Computer.Redwood City, CA: Addison-Wesley; 1991.
